This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.
In a technical report published today, ECDC, proposes a targeted testing approach in areas with ongoing avian influenza outbreaks in poultry and detections in wild birds and other animals, focusing on severe respiratory or unexplained neurological disease.
Tuberculosis (TB) is a major cause of morbidity and mortality in Europe. High-quality laboratory diagnosis of TB is the basis for both individual patient treatment and surveillance.
Today ECDC is providing an update on the current status of COVID-19 transmission in the European Union and European Economic Area (EU/EEA), the emergence of new SARS-CoV-2 variants, and public health considerations for Autumn 2023.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
This Reporting Protocol provides guidelines for data managers in reporting countries on how to prepare data for submission to TESSy, deadlines for reporting, subject-specific information (e.g. new changes to metadata), and links to further information.
In 2023, after several months of very low rates of infection, coronavirus disease 2019 (COVID-19) transmission has started to increase in some EU/EEA countries.